LL-37 5 mg

$20.00

    Purity > 99% – View Lab Test

  • PeptideLL-37
  • Amount5 mg per vial
  • FormLyophilized powder
  • Purity≥99% (HPLC COA available)
  • ManufactureGMP-certified facility
  • Storage (dry)Cool, dry place
  • After reconstitution2–8 °C (short-term); ?20 °C for long-term

Description

LL-37 5 mg — Human Cathelicidin-Derived Antimicrobial Peptide for Innate-Immunity Research

LL-37 is a 37–amino-acid cationic peptide derived from the human
cathelicidin precursor hCAP-18. It is a key component of the innate immune
system
and has been studied extensively for its antimicrobial, immunomodulatory,
and wound-healing–related
properties in preclinical models.

What It Is

  • Class: Human cathelicidin-derived antimicrobial peptide
  • Peptide length: 37 amino acids (C-terminal fragment of hCAP-18)
  • Research focus: Host defense, epithelial barrier biology, biofilm models,
    and inflammation/repair interfaces.

Proposed Mechanisms (Preclinical)

Antimicrobial & Biofilm Activity

  • Exhibits broad-spectrum antimicrobial activity against bacteria,
    some fungi, and enveloped viruses in vitro.
  • Disrupts microbial membranes via cationic, amphipathic interactions
    with lipid bilayers.
  • Investigated in biofilm models for effects on formation,
    disruption, and microbial viability.

Immunomodulation & Tissue Repair

  • Modulates cytokine and chemokine production in immune and epithelial cells.
  • Studied for recruitment and activation of neutrophils, monocytes,
    and other innate immune cells
    .
  • Explored in wound-healing and epithelial-repair models for
    effects on re-epithelialization, angiogenesis, and matrix remodeling.

Selected Research Highlights

  • Skin & Wound Models: LL-37 has been evaluated in cutaneous and
    mucosal injury models for combined antimicrobial and pro-repair effects.
  • Barrier Tissues: Used in respiratory, gut, and urothelial systems to
    study epithelial defense, permeability, and inflammatory signaling.
  • Host-Pathogen Interaction: Experimental work examines the balance between
    microbial killing, immune activation, and potential tissue irritation at higher exposures.

Chemical & Handling Information

  • Type: Synthetic human LL-37 peptide
  • Peptide length: 37 amino acids
  • Appearance: White to off-white lyophilized powder

Specifications

  • Peptide: LL-37
  • Amount: 5 mg per vial
  • Form: Lyophilized powder
  • Purity: ?99% (HPLC); COA per lot available
  • Packaging: Sealed vials suitable for standard laboratory handling

Storage & Stability

  • Store lyophilized vials in a cool, dry place, protected from light.
  • Refrigeration or freezing of the lyophilized peptide is recommended for extended stability,
    according to laboratory SOPs.
  • After reconstitution, store at 2–8 °C for short-term use.
  • For long-term storage, aliquot and freeze at ?20 °C or below; avoid repeated freeze–thaw cycles.

Reviews

There are no reviews yet.

Be the first to review “LL-37 5 mg”

Your email address will not be published. Required fields are marked *